AI MARKET SCANNING

Equillium Inc

📅 Next Catalyst: Nov 11, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -1.46%
MAX GAP RECORD -34.21%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $EQ
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 11, 2026 Earnings Release 2026-11-11 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (BEFORE OPEN)
+0.90%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
-3.03%
Mar 25, 2026 Earnings Release 2026-03-25 (AFTER CLOSE)
-3.40%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
+0.00%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
+2.04%
May 14, 2025 Earnings Release 2025-05-14 (AFTER CLOSE)
+13.51%
Mar 27, 2025 Earnings Release 2025-03-27 (BEFORE OPEN)
-34.21%

VOLATILITY & GAP BIAS

AVG GAP MOVE 6.8%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $EQ

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗